A B S T R A C T The suppression of collagen production by increasing the cyclic (c)AMP content ofcultured cells was examined vis-a-vis the f3-adrenergic system. Cultured human fetal lung fibroblasts incubated for 6 h with the f-agonists isoproterenol or epinephrine produced -30% less collagen per cell than in the absence of the hormones. To demonstrate that the ,B-agonists were operating by their interaction with the ,8-receptor to stimulate adenylate cyclase to increase the intracellular content of cAMP, d-and l-isoproterenol were incubated separately with the cultured cells. Only l-isoproterenol increased intracellular cAMP and decreased collagen production. While 20 nM l-isoproterenol was effective, the d-isomer was ineffective even at 2,M. An increase in cAMP from 40 to 73 pmol/mg protein was effective in suppressing collagen production; increasing the cAMP content to much higher levels had little additional effect on collagen production. 3-Isobutyl-l-methylxanthine, an analog of theophylline that inhibits phosphodiesterase, potentiated the effect of isoproterenol in suppressing collagen production. Further support for the concept that isoproterenol suppressed collagen production by acting through the ,8-receptor was provided by the finding that only the i-isomer of propranolol, a ,8-blocker, was effective in blocking both the increase in intracellular cAMP and the suppression of collagen production caused by isoproterenol. These results demonstrate that collagen production in human fibroblasts can be regulated by the 18-adrenergic system and indicate that when the cAMP content is increased beyond a threshold value, collagen production is suppressed. Since collagen production is sensitive to the small changes of Received for publication 29 May 1980 and in revised form 26 November 1980. in cultured cells, the results point to a possibly important mechanism for the regulation of collagen production in the body. INTRODUCTION Collagen is the major extracellular protein in connective tissues and is present to varying extents in all organs of the body (1-3). In most organs, fibroblasts are the major collagen-producing cells. Normally, fibroblasts from tissues such as skin and lung rigidly control the quantity of collagen they produce at 2-4% of their total protein production (4-6). It is known, however, that collagen production by fibroblasts can be influenced by numerous environmental factors, including hormones, metabolites, and pharmacologic agents (7-10). In addition, recent studies have shown that prostaglandins and cholera toxin dramatically elevate fibroblast cyclic AMP content and suppress collagen production in fibroblasts (11).
A B S T R A C T The suppression of collagen production by increasing the cyclic (c)AMP content ofcultured cells was examined vis-a-vis the f3-adrenergic system. Cultured human fetal lung fibroblasts incubated for 6 h with the f-agonists isoproterenol or epinephrine produced -30% less collagen per cell than in the absence of the hormones. To demonstrate that the ,B-agonists were operating by their interaction with the ,8-receptor to stimulate adenylate cyclase to increase the intracellular content of cAMP, d-and l-isoproterenol were incubated separately with the cultured cells. Only l-isoproterenol increased intracellular cAMP and decreased collagen production. While 20 nM l-isoproterenol was effective, the d-isomer was ineffective even at 2,M. An increase in cAMP from 40 to 73 pmol/mg protein was effective in suppressing collagen production; increasing the cAMP content to much higher levels had little additional effect on collagen production. 3-Isobutyl-l-methylxanthine, an analog of theophylline that inhibits phosphodiesterase, potentiated the effect of isoproterenol in suppressing collagen production. Further support for the concept that isoproterenol suppressed collagen production by acting through the ,8-receptor was provided by the finding that only the i-isomer of propranolol, a ,8-blocker, was effective in blocking both the increase in intracellular cAMP and the suppression of collagen production caused by isoproterenol. These results demonstrate that collagen production in human fibroblasts can be regulated by the 18-adrenergic system and indicate that when the cAMP content is increased beyond a threshold value, collagen production is suppressed. Since collagen production is sensitive to the small changes of cAMP content of cells brought about by ,3-stimulation INTRODUCTION Collagen is the major extracellular protein in connective tissues and is present to varying extents in all organs of the body (1) (2) (3) . In most organs, fibroblasts are the major collagen-producing cells. Normally, fibroblasts from tissues such as skin and lung rigidly control the quantity of collagen they produce at 2-4% of their total protein production (4-6). It is known, however, that collagen production by fibroblasts can be influenced by numerous environmental factors, including hormones, metabolites, and pharmacologic agents (7) (8) (9) (10) . In addition, recent studies have shown that prostaglandins and cholera toxin dramatically elevate fibroblast cyclic AMP content and suppress collagen production in fibroblasts (11) .
In vivo, the cyclic AMP content of cells is controlled, in part, by the 1-adrenergic system (12) . Since Serum Co., Denver, Colo.), penicillin 100 U/ml, streptomycin 100,ug/ml (both from Grand Island Biological, Grand Island, N. Y.), and 0.06% glutamine as previously described (6, 11, 13 (2 ,uM) .
Quantification of collagen production. Following a 6-h incubation with labeling medium in the presence or absence of hormones as described above, collagen production was measured in combined cell layers plus medium using methods described previously (6, 11) . Collagen production2 was expressed in two ways: (a) as a percentage of total protein production; and (b) as an absolute amount of collagen produced. The first method used purified Clostridial collagenase digestion to quantify the [14C]proline incorporated into collagen compared with the ['4C]proline incorporated into total protein (6, 11, 14) . Briefly, the method consisted of scraping the cells from a single culture dish into a plastic tube, using the medium to rinse the plate. The sample was heated to 100°C for 15 min to destroy proteolytic enzymes, sonicated, and dialyzed to remove the unincorporated [14C]proline. The nondialyzable labeled protein was then lyophilized and resuspended in 2.2 ml of 5 mM CaCl2, 2.5 mM N-ethyl maleimide and 10 mM Tris-HCl, pH 7.5. A l-ml aliquot was incubated with 50 U of purified bacterial collagenase (Advanced Biofactures, Lynbrook, N. Y., type III) for 12 h at 20°C in a dialysis bag. The sample was dialyzed against 10 ml H20, and the radioactivity I Abbreviations used in this paper: c, cyclic; IBMX, 3-isobutyl-1-methylxanthine. 2 Fibroblasts actually produce collagen in a precursor form termed "procollagen" or "pre-procollagen" (1, 2) . The methods used here quantify procollagen production (6) , but for convenience the term "collagen" is used to describe the macromolecule.
in both the dialysate and dialysand was determined. The percentage of collagen in the sample was calculated as the amount ofradioactivity sensitive to collagenase divided by the total radioactivity in the sample, multiplied by a correction factor to convert the amount of [14C]proline digested to [14C]-procollagen sensitive to collagenase (6) . Evaluation of this fraction of hydroxy[14C]proline digested with collagenase was used to estimate the efficiency of collagenase digestion (6) . The second method used a combination of collagenase digestion and quantification of the specific activity of the intracellular pool of free [14C]proline to determine the moles of [14C]proline incorporated into collagen per cell per unit time (6) .
Quantification of intracellular cyclic AMP. To determine the intracellular concentration of cyclic AMP, cells were scraped in 5 ml of 10% trichloroacetic acid. After centrifugation, duplicate samples of supernate were taken for determination of cyclic AMP using a protein-binding assay (15) . Protein was determined by the method of Lowry et al. (16) .
Statistical methods. The data are presented as the mean +SE. Differences in collagen production in various experimental conditions were evaluated using the Wilcoxon, MannWhitney Rank Sum test for nonparametric analysis, accepting P < 0.05 as significant (17) .
RESULTS
The ,3-agonists isoproterenol and epinephrine suppressed collagen production in human lung fibroblasts by 30% (P < 0.01) (Fig. 1A) . The suppression of colla- gen production correlated with an increase in the intracellular content of cyclic (c)AMP (Fig. 1B) . To determine if the suppression of collagen production relative to total protein production was specific for collagen, the specific activity of the intracellular pool of [14C]proline was used to calculate the number of moles of proline incorporated into intact collagen and into total, nondialyzable cellular protein. Treatment of the cultures with isoproterenol or epinephrine did not affect the cell number or the specific activity of intracellular proline (not shown). The a-agonist did not affect the amount of proline incorporated into total cellular protein ( Fig. 2A) . However, the absolute amount of proline incorporated into collagen was significantly decreased in cells treated with either isoproterenol or epinephrine (P < 0.01) (Fig. 2B) .
To determine if the ,8-agonists were operating through an interaction with a-receptors, a comparison was made between d-and l-isoproterenol in suppressing collagen production and in increasing the intracellular
The effect of the ,8-agonists isoproterenol and epinephrine on total protein production and collagen production of human lung fibroblasts. Incubation conditions were identical to those described in Fig. 1 . Both overall protein production and collagen production were determined using methods which measure the specific activity of the tracer isotope [14C]proline within the cultured cells, thus accounting for possible differences in tracer specific activity caused by the presence ofa a-agonist (6 content of cAMP (Fig. 3) . The lowest concentration of1-isoproterenol that was effective in decreasing collagen production was 20 nM, a concentration that also raised the intracellular cAMP content of the fibroblasts. In contrast, d-isoproterenol had no effect on collagen production and little effect on cAMP even at 2 ,M.
Further support for a specific interaction between isoproterenol and the 8-receptor in modulating collagen production was obtained by testing the ability of the p-blocker propranolol (18) to inhibit the effect of isoproterenol on suppressing collagen production.
Cells incubated with 2 AM d, 1-isoproterenol demonstrated a reduced production of collagen from 3.8±0.1 to 2.6±0.2% (Fig. 4A) . When the cells were incubated with 2 ,uM d, 1-isoproterenol and 20 nM l-propranolol, collagen production was not suppressed and remained at -3.7+±0.1% (P < 0.5 compared with control). Higher concentrations of l-propranolol up to 2 ,uM were similarly effective in preventing the suppression of collagen production by isoproterenol. In contrast, the d- Further support for a central role of cAMP in suppressing collagen production in fibroblasts was demonstrated by studying the effect of IBMX (Fig. 5) . For collagen production in the presence of d, 1-isoproterenol but not propranolol is suppressed (O) (P < 0.05). In the presence ofd, 1-isoproterenol, increasing levels ofd-propranolol had no effect on the collagen production (P < 0.2, all levels of d-propranolol); however, increasing levels ofl-propranolol did have an effect compared with no propranolol (P < 0.05 at all levels) and compared with the effect ofd-propranolol) (P < 0.05). (B) cAMP levels in parallel cultures expressed as picomoles cAMP per milligram cell protein; each data point represents an average of two culture plates. For the cAMP determinations, half the range averaged <8% of the mean. The average cAMP levels in the absence of isoproterenol and propranolol (A), in the presence of isoproterenol (O), and in the presence of isoproterenol and increasing levels of d-propranolol (0) or l-propranolol (-) are shown.
isomer of propranolol was not effective in preventing the suppression of collagen production by isoproterenol. Isoproterenol in the presence of2 ,tM d-propranolol still suppressed collagen production to 2.9±0.1% from the control value of 3.8+0.1% (P < 0.05). In parallel with these observations, isoproterenol increased intracellular cAMP content from 23 to 130 pmol/mg protein (Fig. 4B ). Propranolol by itself had no significant effect on cAMP (see below), but the addition of as little as 20 nM l-propranolol simultaneously with isoproterenol partially inhibited the /-agonist-induced accumulation of cAMP to 66 pmol/mg. In contrast, the d-isomer FIGURE 5 The potentiation of 8-agonist-induced suppression of fibroblast collagen production cAMP levels by phosphodiesterase inhibition. Culture conditions were similar to those described in Fig. 1. (A) Collagen production expressed as a percentage of total protein production. Shown are control cultures (A) and cultures incubated in the presence of increasing levels ofd, 1-isoproterenol (0) or d, 1-isoproterenol plus 40 1AM IBXIX (0). Each data point represents an average of three culture plates. At 0.2 AiM, isoproterenol significantly suppressed collagen production compared with control cultures (P < 0.05 at all levels). With the addition of IBMX, significant collagen suppression was seen at all isoproterenol levels (P < 0.05 compared with controls, all levels) and IBMX potentiated the suppression observed with isoproterenol alone (P < 0.05, all levels of isoproterenol). and collagen production. The added effect of IBMIX on the isoproterenol suippression of collagen production was also evaluated in the presence and absence of proprainolol (Fig. 6 ). Collagen production was reduced fromii 3.3±0.1% to 2.1±0.1% b) isop)rotereinol aIInd IBMX (P < 0.01). Proprainolol partially blocked this suppression of collagein productioin (2.8+0.1%, P <0.01 comppared with isoproterenol plus IBMX), l)ut dicl not catuse collagen productioin to returin to normal. This wsas likely due to the fhact that proprainolol wN,as not alble to block the effect due to IB\IX alone (2.7±0.1%, P < 0.01 compared with control), a finding consistenit wvith IBMX serving to maintain the level of enclogenious cAM P through its inhibition of phosphodiesterase and not through an effect on the f-receptor.
DISCUSSION
Humi11aii lung fibroblasts rigidlxl control their collagen production both duriing their growth to confluenev and over many populattioni doublings (6) . However, collagein productioin in these cells (19) , atswN7ell as in hiilumia skin fibroblasts (11) , is sensitive to agents which increase intracellular cAMP content. The present studcy demonistrates that the specific interactioni of f-agonists for the fibroblast f-receptor cain be uised to elevate intracellular cAMP and decrease collagen productioni. Changes in cAMP content of cells by as little as a factor of two are effective in suppressing collagen production (Figs. 3 and 5) . Increasing the cAMP content by aii order of magnitude or more (11, 19) has Ino additioinal effect on the suppression of collagen productioin. Since only the i-isoimier of isoproterenol was effective, ain sinice the effect couild be blocked 1v the i-isomer of propranolol, a l3-blocker, the interaction appears to be specific for the fi-receptor-adenylate cvyclase system. Thus, collagen production in cultured humiltani lunig fibroblasts can be regulated by the f-adrenergic system operatiing throuigh relatively small chaniges in intracelltlar cAMP.
The mechanismii for increased cAMP in suppressing collagen production is uinknowin. However, since a variety of ageints which operate through differeint mechanisms to raise cAMP all stuppress collagein production (11, 19) , cAMP apparently plays a ceintral role. Support for the hypothesis that the effect of isoproterenol on collagen production is expressed through intracellular cAMP content was the finding that the effect was potentiated 1y IB MX, a theophylline analog which inhibits phosphodiesterase and therefore acts to maintain levels of intracellular cAMP (20) . Although I-propranolol was able to block the effect of i-isoproterenol, it was not able to block the effect duie to IBMX itself. This finding is consistent with IBMX serving to mainitain a higher intracellular cANMP content throtugh its inhibition of phosphodiesterase, and further clemiioni- The finding that the ,8-blocker l-propranolol can block the effect of 8-agonists on collagen production not only supports the conclusion that the f8-adrenergic receptor-adenylate cyclase system regulates collagen production, but also may have important pharmacological consequences for the regulation of collagen production in the body. All of the 3-blocking agents that have been used clinically, including propranolol, practolol, metoprolol, timolol, and atenolol, have been reported to cause fibrosis (21) (22) (23) (24) (25) (26) . Since the concentration of propranolol used in these experiments was similar to that which is effective in vivo (27) 
